Alternative

Themenbereich / / Alternative


Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

Maricann Group Inc. Announces Incident at Langton Facility

TORONTO, ONTARIO -- (Marketwired) -- 11/15/17 -- Maricann Group Inc. (CSE: MARI)(CSE: MARI.CN)(CNSX: MARI)(OTCQB: MRRCF)(FRANKFURT: 75M) ("Maricann" or the "Company") announced today that a small electrical fire occurred earlier today at its processing facility in Langton, Ontario. The fire was contained to a small area and the smoke was controlled to the immediate area of the fire. All employees followed the Company's safety procedures and were safely evacuated. Cultivation and product storage areas were not affected and damage was limited to a confined area. Electri ...

15.11.2017

GeoVax HIV Clinical Trials Update

ATLANTA, GA -- (Marketwired) -- 11/15/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced that the HIV Vaccine Trials Network (HVTN) has closed enrollment for the phase 1 human clinical trial evaluating late boosts of GeoVax's preventive vaccine (GOVX-B11) for clade B HIV. The trial, designated HVTN 114, is being conducted by the HVTN and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).HVTN 114 began in January 2017, enrolling individuals who previously parti ...

15.11.2017

NetworkNewsWire Announces Publication Featuring Innovative Approach to Cannabis R&D

NEW YORK, NY -- (Marketwired) -- 11/15/17 -- ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring (CSE: IN) (OTCQB: IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.The publication, titled, "Biosynthesis: Making the Impossible Possible in Medicinal Cannabis," reviews the roadblocks and hurdles cannabis researchers face under various regulatory jurisdictions and th ...

15.11.2017

Neptune Announces Second Quarter Results

LAVAL, QUEBEC -- (Marketwired) -- 11/14/17 -- Q2 Financial and Operational Highlights for the 3-month period ended September 30, 2017 compared to the 3-month period ended August 31, 2016(1)Post Quarter End Highlights:Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ: NEPT)(TSX: NEPT), today announced its financial and operating results for the 3-month and 6-month periods ended September 30, 2017. All amounts are in Canadian dollars.Nutraceutical Segment"Our second quarter of fiscal 2018 and the weeks that followed saw us complete a ...

14.11.2017

Breathtec Biomedical Unaware of Any Material Change

VANCOUVER, BC -- (Marketwired) -- 11/14/17 -- Breathtec Biomedical, Inc. (CSE: BTH) (OTCQB: BTHCF) (the "" or "") - at the request of the Investment Industry Regulatory Organization of Canada, Breathtec has confirmed that its management is unaware of any material change in the operations of the Company that would account for the recent market activity. The Company will continue to provide updates of any material changes if and when they occur."Michael Sadhra" Chief Financial Officer & DirectorBreathtec Biomedical, Inc. ("Breathtec") was formed to p ...

14.11.2017

MediXall Group, Inc. Completes Milestones, Looks To Launch MediXaid Platform and Expand Sales & Marketing

FT LAUDERDALE, FL -- (Marketwired) -- 11/14/17 -- MediXall Group Inc. (OTCQB: MDXL) announced today that several significant milestones have been completed. The Company, which initially targeted the South Florida region, will be the first platform of its kind to address the need for consumer-facing healthcare technology and pricing transparency at a level that meets and exceeds regulatory and professional standards, while offering a familiar and convenient user experience, setting MediXaid.com apart from all others.Since inception, MediXall Group and the development team have finalized the (s ...

14.11.2017

Advantis Corp. Hits Home Run with Oregon Deal

NEWPORT BEACH, CA -- (Marketwired) -- 11/14/17 -- (OTC PINK: ADVT) made an agreement to provide Amster-Can services to an Oregon manufacturer (recreational processor) last month. The company says it has ramped up to full production immediately upon receipt of the Amster-Can equipment; Amster-Can branded products are now being sold across the entire state of Oregon, through nearly 400 dispensaries. The company also announced that a new client will distribute all Advantis represented products to the Los Angeles area through its delivery service, Canna Delivery."Amster-Can revenue is set to ...

14.11.2017

eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American Heart Association

WESTBOROUGH, MA -- (Marketwired) -- 11/13/17 -- eXIthera Pharmaceuticals, a clinical stage biotech company focused on discovering and developing effective anticoagulants/antithrombotics without increased bleeding risk or the need for a reversal agent, today announced data from a Phase 1 study of EP-7041, a potent and selective small molecule FXIa inhibitor. EP-7041 was safe and well tolerated in healthy volunteers following single or multiple ascending doses, and the pharmacokinetic (PK) and pharmacodynamic (PD) profile indicated desired efficacy with minimal potential for bleeding.EP-7041 is ...

13.11.2017

Medifirst Solutions to Introduce the Time Machine Laser at the Greater New York Dental Meeting at the Javits Convention Center

FREEHOLD, NJ -- (Marketwired) -- 11/13/17 -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device, is pleased to announce that it is exhibiting at the Greater New York Dental Meeting, a six-day event being held from November 24th to the 29th 2017 at the Jacob K. Javits Convention Center in New York City.Commented Medifirst President Bruce J. Schoengood, "We are very pleased to be introducing our Laser in the biggest ...

13.11.2017

GeoVax to Present at the Third International Conference on Vaccines Research and Development

ATLANTA, GA -- (Marketwired) -- 11/13/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad Guirakhoo, PhD, will deliver a talk, entitled "Development of Novel and Safe Single-Dose Vaccines; Preclinical Efficacy Data for Zika, Ebola and Lassa Fever," during the Third International Conference on Vaccines Research and Development, on Tuesday, November 14 in Washington, DC.Dr. Guirakhoo will discuss GeoVax's vaccine platform which utilizes its recombinant Modified Vaccinia Ankara (MVA) vector ...

13.11.2017

International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial

CARLSBAD, CA -- (Marketwired) -- 11/13/17 -- International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the positive six months interim results of the first cohort of Parkinson's disease (PD) patients receiving 30 million ISC-hpNSC cells in the ongoing clinical study. All patients in the first cohort are currently meeting the primary endpoint, which is safety."We are already seeing some positive efficacy results six months post-transplantation in this 12-mont ...

13.11.2017

BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

FREDERICK, MD -- (Marketwired) -- 11/13/17 -- BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. We are pleased to announce that PharmEvo, our distributor in Vietnam, is hosting an Electroceuticals symposium following a successful launch of their sales & marketing strategy. Additionally, PharmEvo is expanding their territory to cover Cambodia & The Maldives.PharmEvo is hosting a chronic pain symposium titled "Paradigm Shift in Treating Chronic Pain" on November 19th, 2017 in Ho Chi Minh City, Vietnam. The c ...

13.11.2017

Vetter expands its footprint in Asia Pacific region

SONGDO, SOUTH KOREA and RAVENSBURG, GERMANY -- (Marketwired) -- 11/09/17 --, one of the global leaders in , today announced the official opening of a new branch office in South Korea. The new is located within the biologics cluster which is often referred to as a 'sweet spot' by the industry as it houses numerous prominent biopharmaceutical companies and service providers.Strengthening its global footprint in the Asia Pacific (APAC) region has been an ongoing goal for Vetter. The company established its in Singapore in 2014, and subsequently formed a by opening an office in Tokyo ...

10.11.2017

BioElectronics to Showcase Products at World's Largest Medical Tradeshow

FREDERICK, MD -- (Marketwired) -- 11/09/17 -- BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry.The company will share a pavilion hosted by the State of Maryland with 10 other Maryland-based companies in Hall 16, Booth C-18. The tradeshow is set to take place in Dusseldorf, Germany from November 13-16 and will focus on advanc ...

09.11.2017

GeoVax Reports 2017 Third Quarter Financial Results and Development Program Updates

ATLANTA, GA -- (Marketwired) -- 11/09/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its financial results for the quarter ended September 30, 2017, and provided the following update for its research and development programs.GeoVax's product pipeline is based on its Modified Vaccine Ankara (MVA) Virus-Like Particle (VLP) vaccine platform. This platform supports in vivo production of non-infectious VLPs from the cells of the very person receiving the vaccine, mimicking a natural infection ...

09.11.2017

The CIIT Center Managed By Patient Access Solutions, Inc. Announces Hiring of Dr. Robert Goldman, Psy.D., J.D.

COMMACK, NY -- (Marketwired) -- 11/09/17 -- Patient Access Solutions, Inc. (OTC PINK: PASO), a provider of healthcare/financial processing and management solutions for the healthcare and dental industries, proudly announces that Dr. Robert Goldman has joined The CIIT Center as Supervising Psychologist.Dr. Goldman is a licensed psychologist who has been specializing in the practice for over 13 years. Throughout his years of experience, he has learned how toxic stress, including anxiety and depression, can harm the body and focuses on ways to combat its effects. Dr. Goldman gears his treatment ...

09.11.2017

NetworkNewsWire Announces Publication that Highlights Big Pharma's Increasing Interest in Cannabis Biotech Companies

NEW YORK, NY -- (Marketwired) -- 11/09/17 -- ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring (CSE: IN) (OTCQB: IMLFF) a client of NNW specializing in a proprietary in-house cannabinoid biosynthesis platform capable of producing any of the 90+ "downstream" cannabinoids that occur naturally in the cannabis plant.The publication, titled, "Cannabis Biotechs Could be Big Pharma's Latest M&A Focus," discusses the operations of five cannabis biotech companies, several of which have been p ...

09.11.2017

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

VANCOUVER, BC -- (Marketwired) -- 11/09/17 -- . (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the signing of a Binding Letter of Intent with Thrudermic, LLC, a privately held North Carolina company, to acquire worldwide rights to Thrudermic's Transdermal Nanotechnology for the development and commercialization of topical cannabinoids. In addition, Dr. Joseph Borovsky and Dr. Leonid Lurya, Thrudermic's Chief Executive Officer and Chief Technology Officer, respectively, have been appointed to Pivot's Scientific Advisory Board.Thrudermic drug ...

09.11.2017

Veterans Benefit from eHealth Exchange as More Seek Care in Private Sector

VIENNA, VA -- (Marketwired) -- 11/09/17 -- Over 1.3 million veterans have opted-in to permit the Veterans Health Administration (VHA) to securely share their health information for better care coordination with private sector healthcare providers. Having their health information more readily accessible enables these veterans to receive more effective and efficient care when they visit participating , which include nearly 1,000 hospitals, 19,000 clinics, 8,500 pharmacies, 600 labs, and 250 nursing homes."The eHealth Exchange has been working with the Veterans Health Administration since 2 ...

09.11.2017

Nexalin Technology Demonstrates Success in the Treatment of Depression

TUSTIN, CA -- (Marketwired) -- 11/09/17 -- Nexalin Technology is pleased to announce the initiation of clinical trials designed by the University of Pennsylvania to investigate the effectiveness of the Nexalin transcranial stimulation (TACS) for major depressive disorder.A subsidiary of Legacy Ventures International Inc. (OTC PINK: LGYV), Nexalin Technology is an FDA cleared medical device company that utilizes a safe, non-invasive, non-drug treatment for anxiety, depression, and insomnia.The clinical trials, designed independently by Dr. Michael Perlis of the University of Pennsylvania, will ...

09.11.2017


Seite 1 from 177:  1 2  3  4  5  .. » 177





Firmen die firmenpresse.de für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H


I J K L M N O P Q R S T U V W X Y Z